A Food Effect Phase I Study of the Sulfatinib in Healthy Subjects
Latest Information Update: 20 Aug 2020
At a glance
- Drugs Surufatinib (Primary)
- Indications Neuroendocrine tumours; Solid tumours
- Focus Pharmacokinetics
- Sponsors Hutchison MediPharma
- 12 Aug 2020 Results published in the Clinical Therapeutics
- 13 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.